Diogo Rizzato Lara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Diogo Rizzato Lara has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Diogo Onofre Souza
Universidade Federal do Rio Grande do Sul
7 shared publications - Hudson Wander de Carvalho
Departamento de Psicologia, Universidade Federal de Pelotas, Pelotas, Brazil
7 shared publications Gustavo L. Ottoni
Serviço de Psiquiatria, Hospital Presidente Vargas, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre, Porto Alegre, Brazil
6 shared publicationsAnselmo Hoffmann
3 shared publications- Marcelo de Oliveira Dietrich
Laboratory of Physiology of Behavior, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT, USA
3 shared publications Miriam G. Brunstein
3 shared publications
Latest Publications
- 1 September 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 183, 195-204
Validation of the “rule of three”, the “red sign” and temperament as behavioral markers of bipolar spectrum disorders in a large sample
- 1 September 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 183, 195-204
Validation of the “rule of three”, the “red sign” and temperament as behavioral markers of bipolar spectrum disorders in a large sample
- 1 April 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 175, 379-384
The relationship between temperament and sexual orientation
- 1 April 2015
- Published by Elsevier in Journal of Affective Disorders
- Vol. 175, 379-384
The relationship between temperament and sexual orientation
- 1 March 2015
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 62, 123-129
What doesn't kill you makes you stronger and weaker: How childhood trauma relates to temperament traits
- 1 March 2015
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 62, 123-129
What doesn't kill you makes you stronger and weaker: How childhood trauma relates to temperament traits
- Open Access
- 20 January 2015
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 37 (1) , 31-39
Temperament and character traits associated with the use of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens: evidence from a large Brazilian web survey
Key words: Alcohol abuse; psychoactive substance use disorder; other psychological issues; tests/interviews, psychometric; computers
- 20 January 2015
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 37 (1) , 31-39
Open AccessTemperament and character traits associated with the use of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens: evidence from a large Brazilian web survey
Key words: Alcohol abuse; psychoactive substance use disorder; other psychological issues; tests/interviews, psychometric; computers
- 1 December 2014
- Published by Elsevier in Journal of Affective Disorders
- Vol. 169, 30-35
Dysfunctional traits in obese women and underweight men
- 1 December 2014
- Published by Elsevier in Journal of Affective Disorders
- Vol. 169, 30-35
Dysfunctional traits in obese women and underweight men
- 6 September 2014
- Published by Springer Nature
- p. 133-151
The Integration of Mood, Behavior, and Temperament in Mood Spectrum Disorders
- 6 September 2014
- Published by Springer Nature
- p. 133-151
The Integration of Mood, Behavior, and Temperament in Mood Spectrum Disorders
- 1 July 2014
- Published by Elsevier in Journal of Affective Disorders
- Vol. 163, 65-69
Emotional traits and affective temperaments in alcohol users, abusers and dependents in a national sample
- 1 July 2014
- Published by Elsevier in Journal of Affective Disorders
- Vol. 163, 65-69
Emotional traits and affective temperaments in alcohol users, abusers and dependents in a national sample
- Open Access
- 1 October 2013
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 16 (9) , 2111-2117
Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
Intravenous ketamine (0.5 mg/kg) produces robust, rapid and long-lasting antidepressant effects, but is unpractical. Sublingual administration of ketamine renders better bioavailability (∼30%) and less conversion to norketamine than oral administration. We evaluated the therapeutic effects and tolerability of very low dose sublingual (VLDS) racemic ketamine (10 mg from a 100 mg/ml solution for 5 min and swallowed), repeatedly administered every 2–3 d or weekly, in 26 out-patients with refractory unipolar or bipolar depression. According to patients' reports, VLDS ketamine produced rapid, clear and sustained effects, improving mood level and stability, cognition and sleep in 20 patients (77%), with only mild and transient light-headedness as a common side-effect (no euphoria, psychotic or dissociative symptoms). Remission remained in some patients after stopping ketamine. Thus, VLDS ketamine may have broad spectrum effects beyond its antidepressant properties, with rapid onset of action, high efficacy, good tolerability and low cost, allowing extended treatment as needed.
- 1 October 2013
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 16 (9) , 2111-2117
Open AccessAntidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression
Intravenous ketamine (0.5 mg/kg) produces robust, rapid and long-lasting antidepressant effects, but is unpractical. Sublingual administration of ketamine renders better bioavailability (∼30%) and less conversion to norketamine than oral administration. We evaluated the therapeutic effects and tolerability of very low dose sublingual (VLDS) racemic ketamine (10 mg from a 100 mg/ml solution for 5 min and swallowed), repeatedly administered every 2–3 d or weekly, in 26 out-patients with refractory unipolar or bipolar depression. According to patients' reports, VLDS ketamine produced rapid, clear and sustained effects, improving mood level and stability, cognition and sleep in 20 patients (77%), with only mild and transient light-headedness as a common side-effect (no euphoria, psychotic or dissociative symptoms). Remission remained in some patients after stopping ketamine. Thus, VLDS ketamine may have broad spectrum effects beyond its antidepressant properties, with rapid onset of action, high efficacy, good tolerability and low cost, allowing extended treatment as needed.
- 1 August 2013
- Published by Elsevier in Psychiatry Research
- Vol. 209 (1) , 110-113
Polymorphisms in schizophrenia candidate gene UFD1L may contribute to cognitive deficits
- 1 August 2013
- Published by Elsevier in Psychiatry Research
- Vol. 209 (1) , 110-113
Polymorphisms in schizophrenia candidate gene UFD1L may contribute to cognitive deficits
- 1 March 2013
- Published by Elsevier in Addictive Behaviors
- Vol. 38 (3) , 1859-1864
How emotional traits and affective temperaments relate to cocaine experimentation, abuse and dependence in a large sample
- 1 March 2013
- Published by Elsevier in Addictive Behaviors
- Vol. 38 (3) , 1859-1864
How emotional traits and affective temperaments relate to cocaine experimentation, abuse and dependence in a large sample